Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Asahimas Flat Glass Tbk (AMFG) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)

Asahimas Flat Glass TbkTrading
Brigit Biofarmaka Teknologi Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Asahimas Flat Glass Tbk dan Brigit Biofarmaka Teknologi Tbk.: Asahimas Flat Glass Tbk diperdagangkan di Rp3.330 (kapitalisasi pasar 1,44 T, volume 24 jam 3,5 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 177,8 rb). Perbedaan utamanya: Asahimas Flat Glass Tbk jauh lebih besar — sekitar 8,7× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (177,8 rb vs 3,5 rb). Mana yang lebih baik tergantung tujuan investasimu.

AMFGOBAT
Kapitalisasi Pasar
1,44 T164,65 M
Volume
3,5 rb177,8 rb
Lot
351,78 rb
Perputaran
11,62 jt42,05 jt
Harga Rata-rata
3.320,57236,47
Nilai Transaksi
11,62 jt42,05 jt
Harga Ekuilibrium Indikatif
242
Volume Ekuilibrium Indikatif
500

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

AMFG
Lihat detail
OBAT
Lihat detail

Tentang Asahimas Flat Glass Tbk

PT. Asahimas Flat Glass Tbk (The Company) was established within the foreign capital investment framework of Law No. 1 of 1967 and Law No. 11 of 1970, by deed of notary public Koerniatini Karim dated 7 October 1971 No. 4, as amended by deed of the same notary dated 6 January 1972 No. 9; these deeds were approved by the Minister of Justice under No. J.A.5/5/19 dated 17 January 1972. The Company is a joint venture between Asahi Glass of Japan and the Rodamas Group of Indonesia. Asahi Glass is one of the leading glass producers in the world.

Selengkapnya di halaman AMFG

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT